Differential macular and peripheral expression of bestrophin in human eyes and its implication for Best disease

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 7, 2007, Pages 3372-3380

  Mullins, Robert F ^a   Kuehn, Markus H ^a   Faidley, Elizabeth A ^a   Syed, Nasreen A ^a   Stone, Edwin M ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BESTROPHIN; GLYCOCONJUGATE; LIPID; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; BEST1 PROTEIN, HUMAN; CHLORIDE CHANNEL; EYE PROTEIN;

ADULT; AGED; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MALE; PIGMENT CELL; PIGMENT EPITHELIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RETINA MACULA LUTEA; RETINA MACULA VITELLIFORM DEGENERATION; WESTERN BLOTTING; CONFOCAL MICROSCOPY; DONOR; GENE EXPRESSION; GENETICS; LIPID METABOLISM; METABOLISM; MIDDLE AGED; MUTATION; PEDIGREE; RETINA DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CHLORIDE CHANNELS; EYE PROTEINS; FEMALE; GENE EXPRESSION; GLYCOCONJUGATES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MUTATION; PEDIGREE; PIGMENT EPITHELIUM OF EYE; RETINAL DEGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DONORS;

EID: 34548106017     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0868     Document Type: Article

References (50)

1. Best F. Über eine hereditare maculaaffektion: bietrage zur vererbungslehre. Z Augenheilkd. 1905;13:199-212.
2. Weleber R. Fast and slow oscillations of the electro-oculogram in Best's macular dystrophy and retinitis pigmentosa. Arch Ophthalmol. 1989;107:530-537.
3. Blodi C, Stone E. Best's vitelliform dystrophy. Ophthalmic Paediatr Genet. 1990;11:49-59.
4. Sorr E, Goldberg R. Vitelliform dystrophy in a 64 year old man. Am J Ophthalmol. 1976;82:256-8.
5. Mullins R, Oh K, Heffron E, Hageman G, Stone E. Late development of vitelliform lesions and flecks in a patient with Best's disease: clinicopathologic correlation. Arch Ophthalmol. 2005;123:1588-1594.
6. Renner A, Tillack H, Kraus H, et al. Late onset is common in best macular dystrophy associated with VMD2 gene mutations. Ophthalmology. 2005;112:586-592.
7. Petrukhin K, Koisti M, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998;19:241-247.
8. Marquardt A, Stohr H, Passmore L, Kramer F, Rivera A, Weber B. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). Hum Mol Genet. 1998;7:1517-1525.
9. Marmorstein A, Marmorstein L, Rayborn M, Wang X, Hollyfield J, Petrukhin K. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA. 2000;97:12758-12763.
10. Tsunenari T, Sun H, Williams J, et al. Structure-function analysis of the bestrophin family of anion channels. J Biol Chem. 2003;278:41114-41125.
11. Milenkovic VM, Rivera A, Horling F, Weber BH. Insertion and topology of normal and mutant bestrophin-1 in the endoplasmic reticulum membrane. J Biol Chem. 2006;282:1313-1321.
12. Hartzeil C, Qu Z, Putzier I, Artinian L, Chien L, Cui Y. Looking chloride channels straight in the eye: bestrophins, lipofuscinosis, and retinal degeneration. Physiology. 2005;20:292-302.
13. Allikmets R, Seddon J, Bernstein P, et al. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet. 1999;104:449-453.
14. Lotery A, Murder F, Fishman G, et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:1291-1296.
15. Sun H, Tsunenari T, Yau K, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Nat Acad Sci USA. 2002;99:4008-4013.
16. Marmorstein A, Stanton J, Yocom J, et al. A model of best vitelliform macular dystrophy in rats. Invest Ophthalmol Vis Sci. 2004;45:3733-3739.
17. Hu J, Bok D. A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis. 2001;7:14-19.
18. Ohno-Matsui K, Ichinose S, Nakahama K, et al. The effects of amniotic membrane on retinal pigment epithelial cell differentiation. Mol Vis. 2005;11:1-10.
19. Qu Z, Wei R, Mann W, Hartzell H. Two bestrophins cloned from Xenopus laevis oocytes express Ca(2+)activated Cl(-) currents. J Biol Chem. 2003;278:49563-49572.
20. Qu Z, Hartzell C. Determinants of anion permeation in the second transmembrane domain of the mouse bestrophin-2 chloride channel. J Gen Physiol. 2004;124:371-382.
21. Fischmeister R, Hartzell H. Volume sensitivity of the bestrophin family of chloride channels. J Physiol. 2005;562:477-491.
22. Krill A, Morse P, Potts A, Klien B. Hereditary vitelliruptive macular degeneration. Am J Ophthalmol. 1966;61:1405-1415.
23. + channels in retinal pigment epithelial cells. FASEB J. 2006;20:178-180.
24. Stanton JB, Goldberg AF, Hoppe G, Marmorstein LY, Marmorstein AD. Hydrodynamic properties of porcine bestrophin-1 in Triton X-100. Biochim Biophys Acta. 2006;1758:241-247.
25. Marmorstein LY, Wu J, McLaughlin P, et al. The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1). J Gen Physiol. 2006;127:577-589.
26. Guziewicz K, Zangerl B, Lindauer S, et al. Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for Best disease. Invest Ophthalmol Vis Sci. 2007;48:1959-1967.
27. Pianta MJ, Aleman TS, Cideciyan AV, et al. In vivo micropathology of Best macular dystrophy with optical coherence tomography. Exp Eye Res. 2003;76:203-211.
28. Littann K. Multiple vitelliforme netzhautcysten. Ber Dtsch Ophthalmol Ges. 1965;67:442-446.
29. Mullins R, Skeie J, Malone E, Kuehn M. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Mol Vis. 2006;12:224-235.
30. Mullins R, Grassi M, Skeie J. Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration. Mol Vis. 2005;11:509-517.
31. Russell S, Mullins R, Schneider B, Hageman G. Basal laminar drusen are indistinguishable in location, substructure, and composition from drusen associated with aging and age-related macular degeneration. Am J Ophthalmol. 2000;129:205-214.
32. Weingeist T, Kobrin J, Watzke R. Histopathology of Best's macular dystrophy, Arch Ophthalmol. 1982;100:1108-1114.
33. Mullins R, Anderson D, Russell S, Hageman G. Ocular drusen contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-846.
34. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
35. McLaughlin B, Fan W, Zheng J, et al. Novel role for a complement regulatory protein (CD46) in retinal pigment epithelial adhesion. Invest Ophthalmol Vis Sci. 2003;44:3669-3674.
36. Holz F, Sheraiadah G, Pauleikhoff D, Marshall J, Bird A. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol. 1994;112:402-406.
37. Chong N, Keonin J, Luthert P, et al. Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to distribution of lesions associated with AMD. Am J Pathol. 2005;166:241-251.
38. Lawwill T. Three major pathologic processes caused by light in the primate retina: a search for mechanisms. Trans Am Ophthalmol Assoc. 1982;80:517-579.
39. Curcio CA, Sloan KR Jr, Packer O, Hendrickson AE, Kalina RE. Distribution of cones in human and monkey retina: individual variability and radial asymmetry. Science. 1987;236:579-582.
40. Curcio CA. Photoreceptor topography in ageing and age-related maculopathy. Eye. 2001;15:376-383.
41. Goldberg MF, Lee FL, Tso MO, Fishman GA. Histopathologic study of autosomal dominant vitreoretinochoroidopathy: peripheral annular pigmentary dystrophy of the retina. Ophthalmology. 1989;96:1736-1746.
42. Yardley J, Leroy B, Hart-Holden N, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45:3683-3689.
43. Esumi N, Kachi S, Campochiaro PA, Zack DJ. VMD2 promoter requires two proximal E-box sites for its activity in vivo and is regulated by the MITF-TFE family. J Biol Chem. 2007;282:1838-1850.
44. Anderson DH, Fisher SK, Erickson PA, Tabor GA. Rod and cone disc shedding in the rhesus monkey retina: a quantitative study. Exp Eye Res. 1980;30:559-574.
45. Bobu C, Craft CM, Masson-Pevet M, Hicks D. Photoreceptor organization and rhythmic phagocytosis in the Nile rat Arvicanthis ansorgei: a novel diurnal rodent model for the study of cone pathophysiology. Invest Ophthalmol Vis Sci. 2006;47:3109-3118.
46. Andrade RE, Farah ME, Costa RA. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease. Am J Ophthalmol. 2003;136:1179-1181.
47. Chung MM, Oh KT, Streb LM, Kimura AE, Stone EM. Visual outcome following subretinal hemorrhage in Best disease. Retina. 2001;21:575-580.
48. Kemp C, Jacobson S, Cideciyan A, Kimura A, Sheffield V, Stone E. RDS gene mutations causing retinitis pigmentosa or macular degeneration lead to the same abnormality in photoreceptor function. Invest Ophthalmol Vis Sci. 1994;35:3154-3162.
49. Braley A, Spivey B. Hereditary vitelline macular degeneration. Arch Ophthalmol. 1964;72:743-762.
50. Seddon JM, Sharma S, Chong S, Hutchinson A, Allikmets R, Adelman RA. Phenotype and genotype correlations in two best families. Ophthalmology. 2003;110:1724-1731.